CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 80 filers reported holding CATALYST BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $51,000 | -88.7% | 77,127 | -84.3% | 0.00% | – |
| Q4 2021 | $450,000 | -86.3% | 492,701 | -38.5% | 0.00% | -100.0% |
| Q3 2021 | $3,294,000 | -17.8% | 801,440 | -13.4% | 0.00% | 0.0% |
| Q2 2021 | $4,008,000 | -12.2% | 925,706 | +2.0% | 0.00% | -50.0% |
| Q1 2021 | $4,565,000 | -8.4% | 907,596 | +14.9% | 0.00% | 0.0% |
| Q4 2020 | $4,986,000 | +48.7% | 790,169 | +1.3% | 0.00% | +100.0% |
| Q3 2020 | $3,353,000 | -24.8% | 779,792 | +2.7% | 0.00% | -50.0% |
| Q2 2020 | $4,456,000 | +33.7% | 759,055 | -0.5% | 0.00% | 0.0% |
| Q1 2020 | $3,334,000 | -33.0% | 762,876 | +4.5% | 0.00% | 0.0% |
| Q4 2019 | $4,973,000 | +36.4% | 730,238 | -1.7% | 0.00% | +100.0% |
| Q3 2019 | $3,647,000 | -31.6% | 742,794 | +2.6% | 0.00% | -50.0% |
| Q2 2019 | $5,335,000 | -1.1% | 723,873 | +8.8% | 0.00% | 0.0% |
| Q1 2019 | $5,396,000 | +34.6% | 665,323 | +30.9% | 0.00% | 0.0% |
| Q4 2018 | $4,010,000 | -8.0% | 508,232 | +25.7% | 0.00% | 0.0% |
| Q3 2018 | $4,359,000 | +131.1% | 404,358 | +150.1% | 0.00% | +100.0% |
| Q2 2018 | $1,886,000 | -58.5% | 161,653 | -8.3% | 0.00% | -50.0% |
| Q1 2018 | $4,546,000 | +89.1% | 176,211 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $2,404,000 | +175.4% | 176,211 | +1.5% | 0.00% | – |
| Q3 2017 | $873,000 | +134.7% | 173,555 | +117.0% | 0.00% | – |
| Q2 2017 | $372,000 | – | 79,963 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,635,014 | $10,830,000 | 4.93% |
| 22NW, LP | 1,429,242 | $5,874,000 | 1.75% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,110,000 | 1.20% |
| Sio Capital Management, LLC | 623,892 | $2,564,000 | 0.82% |
| ACUTA CAPITAL PARTNERS, LLC | 365,000 | $1,500,000 | 0.53% |
| Nantahala Capital Management | 2,432,212 | $9,996,000 | 0.32% |
| Parkman Healthcare Partners LLC | 133,449 | $548,000 | 0.14% |
| Ikarian Capital, LLC | 454,346 | $1,867,000 | 0.13% |
| Orbimed Advisors | 2,711,600 | $11,145,000 | 0.12% |
| AlphaCentric Advisors LLC | 114,000 | $469,000 | 0.12% |